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Abstract Recombinant P450 2B1 wild-type and the active-site 
mutants I114V, F206L, V363A, V363L, and G478S were 
purified and studied. The efficiency of coupling of reducing 
equivalents to 7-hydroxycoumarin formation was decreased for 
all the mutants except II 14V. Uncoupling to H_»0 was increased 
for F206L, V363A, and G478S, decreased for V363L, and 
unchanged for II 14V. Uncoupling to H2C>2 was increased for 
V363L and decreased for I114V, F206L, and V363A. The 
findings from this study provide firm biochemical evidence that 
residues 206, 363, and 478 comprise part of the substrate binding 
site of P450 2B1. 
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1. Introduction 
The cytochrome P450 (P450) superfamily is responsible for 
the oxidation of a wide range of drugs, carcinogens, environ-
mental pollutants, and other xenobiotics in species ranging 
from human to bacteria. Any given P450 enzyme usually 
has the ability to metabolize a number of different substrates, 
and different P450s often exhibit overlapping specificities [1]. 
Identifying the structural determinants of substrate specificity 
and inhibitor selectivity of P450 2B forms from various spe-
cies including rat [2-6], rabbit [7,8], and dog [9-11] has been a 
major interest of this laboratory in recent years. Site-directed 
mutagenesis studies have shown that residues 114, 206, 290, 
294, 302, 363, 367, and 478 in P450 2B enzymes determine the 
substrate specificity and regio- or stereoselectivity and suggest 
that these residues are found within substrate recognition sites 
[2-6,11-14]. These residues have counterparts in active-site 
residues in mammalian P450 2A and 2C enzymes [15] and 
in bacterial P450s such as P450 101 and 102 [12,16,17]. 
Recent studies of P450 101 mutants have revealed interest-
ing correlations between the identity and location of key res-
idues and the efficiency of coupling of pyridine nucleotide 
derived reducing equivalents to product formation [16,17]. 
With the preferred substrate camphor, P450 101 yields 1 mol 
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of product for each mol of NADH consumed [18,19], whereas 
uncoupling is observed during the metabolism of other sub-
strates such as ethylbenzene [16]. The cytochrome P450 cata-
lytic cycle is complex and consists of at least seven discrete 
steps (Fig. 1). Uncoupling occurs in the reaction cycle at three 
branch points marked by substrate-bound oxy-ferrous 
([Fe02]2+-RH), peroxy-ferric ([Fe02H]2+-RH), and iron-oxo 
([FeO]3+-RH) intermediates, yielding Superoxide, hydrogen 
peroxide, and excess water, respectively. The stoichiometry 
of mammalian cytochrome P450 catalyzed reactions has 
been studied both in microsomes and in reconstituted systems 
[20,21], and uncoupling at one or more of the three branch 
points is common [20,22]. Only limited information is avail-
able, however, on the role of individual residues in determin-
ing coupling efficiency of mammalian P450s. Docking of 7-
ethoxycoumarin in the active pocket of a 3D model of P450 
2B1 [12] has revealed that residues 114, 206, 363, and 478 are 
all within 5 A from the substrate (Fig. 2). In order to obtain 
biochemical evidence for the role of these residues in substrate 
recognition, we have studied the stoichiometry of the deethy-
lation of ethoxycoumarin by recombinant P450 2B1 wild-type 
and the mutants II14V, F206L, V363A, V363L, and G478S. 
As predicted for active-site residues, uncoupling to water was 
drastically altered in three of the mutants compared with the 
wild-type enzyme. 
2. Materials and methods 
2.1. Materials 
HEPES was obtained from Calbiochem Corporation (La Jolla, 
CA), and all other chemicals were obtained from Sigma and were 
of the highest grade available. 
2.2. Purification 
P450 2B1 wild-type and the mutants II14V, F206L, V363A, V363L, 
and G478S were expressed in an Escherichia coli system as described 
[6]. The recombinant enzymes were purified using the previously pub-
lished two-column protocol (я-octylamino Sepharose, hydroxyapatite) 
[23] with some modifications. The starting material was CHAPS-solu-
bilized membrane preparations representing 50-100 nmol P450/1 cul-
ture, with a specific P450 content of > 1 nmol/mg protein and min-
imal cytochrome P420 contamination. Refinements to the octylamino 
Sepharose chromatography procedures included optimizing the 
amount of P450 applied (5 nmol/ml gel) and eluting with 0.1% Emul-
gen 913 instead of 0.08% Lubrol. Improved recovery from the hy-
droxyapatite chromatography was achieved by decreasing the pH of 
the equilibration and wash buffers from 7.5 to 6.5 and deleting the 
EDTA. 
2.3. Reconstitution and enzymatic reaction 
The reconstituted system of P450 2B1 wild-type or mutants con-
tained 2.5 μΜ P450, 1.9 μΜ recombinant NADPH-cytochrome P450 
reductase [24], and 36 μg/ml DLPC and was equilibrated at room 
temperature for 10 min prior to use. The molar ratio of P450 reduc-
tase :P450 of 0.75 was used in order to minimize the contribution of 
the reductase alone to hydrogen peroxide formation [22]. The reaction 
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mixture contained 0.095 μΜ enzyme, 0.071 μΜ reductase, 300 μΜ 7-
ethoxycoumarin, 15 μΜ MgCl2, 30 μ^piιΐ DLPC, and 0.05 M 
HEPES, pH 7.4. The HEPES buffer was freed of iron by passing 
through a Chelex column. The reaction was initiated by adding 20 
mM NADPH to achieve an initial concentration of 0.20 mM and 
quenched after 10 min by adding 1/10 volume of 0.5 M sulfuric 
acid. Spectrophotometric measurement of NADPH oxidation and 
polarographic measurement of oxygen consumption were performed 
in two parallel reactions derived from the same reaction mixture and 
thermostated at 37°C from the same water bath. After quenching, 
H2O2 and 7-hydroxycoumarin were measured in both samples. 
2.4. 7-Hydroxycoumarin formation 
7-Hydroxycoumarin formed in the reaction was quantified using the 
previously described fluorometric method [25] with some modifica-
tions. 100 μΐ of the quenched reaction mixture was extracted with 
1.5 ml of chloroform; then 1.0 ml of 30 mM sodium borate was 
used to extract the product from 0.6 ml of the chloroform phase. 
The concentration of product in the borate solution was determined 
from its fluorescence recorded on a Hitachi F-2000 fluorescence spec-
trophotometer using excitation and emission wavelengths of 366 and 
454 nm, respectively. Authentic 7-hydroxycoumarin was quantita-
tively recovered under the extraction conditions employed. 
2.5. NADPH oxidation 
The reaction was performed in a spectrophotometric cuvette ther-
mostated at 37°C. Because 7-ethoxycoumarin absorbs strongly at 340 
nm, reactions were monitored at 362 nm, at which the NADPH vs. 7-
ethoxycoumarin difference spectrum shows a peak. The rate of 
NADPH oxidation was calculated from the corrected absorbance 
change at 362 nm. The correction was made by subtraction of the 
absorbance change caused by conversion of 7-ethoxycoumarin to 7-
hydroxycoumarin from the spectrophotometrically recorded absorb-
ance change at 362 nm. At 362 nm the molar difference extinction 
coefficient between 7-hydroxycoumarin and 7-ethoxycoumarin is 4.44 
M _ 1 cm - 1 , whereas the molar extinction coefficient of NADPH is 
4.08 M"1 cm"1. 
2.6. Oxygen consumption 
The reaction was performed in a RC-1 respiration cell obtained 
from Cameron Instrument Company (Port Aransas, TX). The respi-
ration cell was equipped with a Clark-type electrode, a teflon-coated 
stirring bar, a plunger with a narrow hole in its center for sample 
delivery, and a water-circulation jacket. The oxygen electrode was 
connected to an OM 2000 Oxygen Meter obtained from Cameron 
Instrument Company, and the output from the oxygen meter was 
recorded on a Curken chart recorder. The oxygen measurements 
were standardized by two methods: (1) addition of increments of 
37°C air-saturated deionized water to air-free nitrogen-saturated 
water thermostated at 37°C, (2) using two standard solutions: air-
saturated water and dithionite solution. Since the slopes of the cali-
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Fig. 1. Cytochrome P450 catalytic cycle. [Fe]3+ : substrate-free ferric 
P450. RH: substrate. ROH: hydroxylated product. 
Fig. 2. 7-Ethoxycoumarin docked into the active site of the P450 
2B1 model in an orientation allowing for O-deethylation. The sub-
strate is shown in gray, with all hydrogens displayed. Key residues 
114, 206, 363, and 478 are within 5 A of 7-ethoxycoumarin. 
bration curves prepared from the above two methods did not differ 
from each other by more than 1%, the instrument was routinely cali-
brated by the two-standard method. Under the atmospheric pressure, 
686 mm Hg, in our laboratory, the calculated oxygen concentration of 
deionized water saturated with air at 37°C is 177 μΜ [26] using the 
calculated oxygen solubility in pure water 6.73 mg/1 at 37°C under 760 
mm Hg [27]. The oxygen concentration in the reaction mixture at 
37°C was 177 μΜ, determined from the calibration curve. To initiate 
a reaction, NADPH was injected to the respiration cell through the 
narrow central hole with the aid of a micro-syringe. Minor absorption 
of oxygen from the surroundings through the central hole during the 
reaction was ignored. 
2.7. Hydrogen peroxide production 
The H2O2 produced in reactions was determined using the xylenol 
orange iron(III) colorimetrie assay [28] with some modifications. An 
assay sample was prepared by mixing 100 μΐ of the quenched reaction 
mixture with 890 μΐ of 25 mM sulfuric acid, 10 μΐ of deionized water, 
and 17.5 μΐ of the color developing agent and incubating at room 
temperature for 1 h. The color developing agent was made prior to 
use by mixing 1 volume of 20 mM xylenol orange with 2.5 volumes of 
20 mM fresh ferrous ammonium sulfate. The calibration curve was 
prepared from a series of solutions each of which contained 100 μΐ of 
the quenched reaction mixture, 890 μΐ of 25 mM sulfuric acid, 10 μΐ of 
H2O2 standard solution of different concentrations, and 17.5 μΐ of the 
color developing agent. The Н2Ог standard solutions were prepared 
by dilution of a 30% H2O2 stock solution with deionized water. The 
exact concentration of H2O2 in the stock solution was calculated 
using the molar extinction coefficient of 43.6 M _ 1 cm - 1 at 240 nm 
[28]. Control experiments confirmed that added Н2Ог was recovered 
quantitatively from reaction mixtures. 
3. Results and discussion 
3.1. Enzyme characterization 
The purification procedures resulted in wild-type and mu-
tant preparations with a single major band on SDS-PAGE 
(Fig. 3) and with a specific content of > 14 nmol P450/mg 
protein and < 5% P420. The Chromatographie procedures 
yielded approximately 10-20 nmol purified P450/1 culture. 
Catalytic integrity was confirmed using androstenedione as a 
substrate. As shown in Fig. 4, the activity of recombinant 
P450 2B1 was the same as the purified hepatic enzyme. In 
addition, all mutants showed activities equal to or higher 
than the membrane preparations (data not shown). 
3.2. Stoichiometry of 7-ethoxycoumarin deethylation 
The rates of N A D P H and oxygen consumption, product 
formation, and hydrogen peroxide and excess water produc-
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Fig. 3. Coomassie blue-stained SDS-PAGE gel of purified hepatic 
and recombinant P450 2B1 wild-type and five active-site mutants. 
Each lane contained 1 μg of protein. 
tion during 7-ethoxycoumarin metabolism by the wild-type 
and mutant enzymes are presented in Table 1. Formation of 
Superoxide as an uncoupling product was not measured di-
rectly, due to the difficulty in making quantitative determina-
tion of this very reactive and unstable species [22]. Inclusion 
of Superoxide dismutase yielded no increase in the amount of 
H2O2 peroxide detected, confirming that Superoxide formed 
during the reaction was spontaneously dismutated to H 2 0 2 
rather than reacting with other components of the incubation 
mixture. Therefore, measurements of hydrogen peroxide for-
mation served as an indicator of dissociation of oxygen from 
the [Fe02]2+-RH or [Fe02H]2+-RH intermediates [16,20,22]. 
The rates of the excess water formation presented in Table 1 
were calculated from (1) the difference between the rate of 
NADPH oxidation and rates of hydrogen peroxide plus prod-
uct formation and (2) the difference between the rate of oxy-
gen consumption and rates of hydrogen peroxide plus product 
formation [16,22]. The results from both calculations were in 
fair agreement within experimental errors except for the mu-
tant F206L, indicating that no major products other than 7-
hydroxycoumarin were formed during the reaction. 
3.3. Uncoupling to hydrogen peroxide and water by active-site 
mutants 
The ratio of product formation:NADPH oxidized is pre-
sented in Table 2 in order to show the efficiency of the wild-
type and mutant P450 2B1 in coupling of reducing equivalents 
to product. In addition to the ratios of H2O2 production: 
NADPH oxidation and H 2 0 formation:NADPH oxidation, 
the ratio of the rates of H 2 0 2 production :0 2 consumption 
Fig. 4. Autoradiogram of androstenedione metabolites produced by 
hepatic and recombinant P450 2B1 and five active-site mutants. The 
100-μ1 reaction mixture contained 5 pmol of the purified enzyme, 10 
pmol of NADPH-cytochrome P450 reductase, 10 pmol of cyto-
chrome b^, and 25 μΜ substrate and proceeded for 5 min as de-
scribed [2]. 
and the ratio of the rates of H 2 0 formation:product forma-
tion are also presented in Table 2. Use of the H 2 0 2 : 0 2 ratio 
instead of the H 2 0 2 : NADPH ratio to analyze uncoupling at 
the first or second branch point shown in Fig. 1 eliminates the 
effect of the reducing equivalents used by the enzyme to form 
water at the third branch point [16]. Similarly, use of the 
H2О : product ratio instead of the H 20:NADPH ratio to as-
sess uncoupling at the third branch point accounts for the loss 
of reducing equivalents to hydrogen peroxide production at 
the first or second branch point [16]. 
As shown in Table 2, the mutant II 14V exhibits higher 
efficiency of coupling of reducing equivalents to product for-
mation than P450 2B1 wild-type. For II 14V, uncoupling to 
H 2 0 2 production is decreased, whereas uncoupling to water 
formation is essentially unchanged. In contrast, the mutants 
V363L, F206L, V363A, and G478S all exhibit decreased effi-
ciencies of coupling of reducing equivalents to product for-
mation. For V363L decreased coupling efficiency is correlated 
Table 1 
Rates (nmol/min/nmol) determined for 7-ethoxycoumarin metabolism by P450 2B1 wild-type and five active-site mutants8 
P450 2B1 NADPH oxidized O2 consumed Product formed H2O2 produced Excess H20 formed 
Wild-type 
Il 14V 
F206L 
V363A 
V363L 
G478S 
42.4 ±3.1 
25.4 ±0.8 
21.3 ±0.03 
20.3 ±0.5 
36.5 ±0.4 
16.9 ±0.7 
34.0 ±0.9 
19.1 ±1.0 
10.4 ±1.2 
11.8±0.5 
35.4 ±0.7 
10.9±1.5 
5.0 ±0.2 
4.2 ±0.2 
0.77 ±0.06 
0.33 ±0.05 
2.98 ± 0.07 
0.28 ± 0.04 
18.6±1.7 
6.9 ±0.5 
4.8 ±1.2 
3.6 ±0.3 
28.0 ±0.9 
6.4 ±0.4 
Eq. 1 
18.8 ±1.8 
14.3 ±1.0 
16.3 ±0.4 
16.4 ±0.5 
5.3 ±1.3 
10.3 ±1.1 
Eq. 2 
20.7 ±3.5 
16.1 ±1.4 
l l . O i l . 5 
15.6± 1.4 
8.5 ±1.9 
8.5±2.8 
aThe means and standard deviations were calculated from three independent experiments performed with 0.1 μΜ reconstituted P450 incubated for 
10 min at 37°C. 
bEq. 1: H20 = NADPH-H202-product. Eq. 2: Η20 = 2(θ2-Η2θ2 -product). 
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Table 2 
Effect of active-site mutations on coupling to product formation 
and uncoupling to hydrogen peroxide and water formation 
P450 2B1 Product" H202 H2Oa H 2 0 
Wild-type 
Il 14V 
V363L 
F206L 
V363A 
G478S 
0.12 
0.16 
0.082 
0.034 
0.016 
0.016 
0.44 
0.27 
0.77 
0.20 
0.18 
0.38 
0.55 
0.36 
0.80 
0.40 
0.31 
0.59 
0.44 
0.56 
0.15 
0.77 
0.80 
0.61 
3.7 
3.5 
1.8 
23 
50 
38 
ratios of product:NADPH, H202:NADPH, and "Expressed as 
H20:NADPH. bExpressed as ratio of H202:02. c Expressed as ratio of H2 О : product. dExcess H20 formation used in calculation of H20:product ratio was 
determined from Eq. 1 in Table 1. Excess H20 formation may also be 
calculated from NADPH and 02 consumption using H20 = 
2(NADPH—02), the result of which is independent of product formed 
during the reaction. According to this latter calculation, the 
H20:product ratios of the enzymes in the same order as listed in 
the table are 3.4, 3.0, 0.7, 30, 50, and 43, respectively. 
with increased uncoupling to H2O2. This leads to less 
[FeO]3+-RH intermediate formation and consequently less 
product formation. At the third branch point shown in Fig. 
1, however, the putative [FeO]3+-RH intermediate of V363L 
substantially favors product formation. For mutants F206L, 
V363A, and G478S, decreased efficiencies of coupling of re-
ducing equivalents to product formation are correlated with 
significantly increased uncoupling to water formation at the 
level of the putative [FeO]3+-RH intermediate. Studies with 
P450 101 have shown that water formation is inhibited when 
the bound molecule is tightly packed into the active site [29]. 
A change from Ala to Val or from Val to Leu at position 363 
increases the volume of the aliphatic side chain and presum-
ably causes 7-ethoxycoumarin to be more tightly packed in 
the active pocket. The results obtained with mutants V363A 
and V363L indeed show that uncoupling to water formation 
decreases with an increase in the volume of the aliphatic side 
chain. Increased uncoupling to water for F206L and G478S, 
however, implies that factors other than volume of the side 
chain may also affect the complementarity between bound 
substrate and the active pocket. It is also inferred from the 
Н20г:02 ratios presented in Table 2 that an increase in vol-
ume of the side chain of residues 114 and 363 is correlated 
with increased uncoupling to H2O2. It should be noted that 
these particular correlations between residue volume and un-
coupling may not be valid for other P450 2B enzymes or with 
P450 2B1 and other substrates. For example, when the vol-
ume of residue 363 increases, the monooxygenase activity can 
increase or decrease depending on the specific P450 2B en-
zyme and substrates used [5,6,11,14]. 
In summary, the findings from the stoichiometry of 7-
ethoxycoumarin metabolism provide firm biochemical evi-
dence that residues 206, 363, and 478 comprise part of the 
substrate binding site of P450 2B1. The results have important 
implications for engineering P450s of increased efficiency. 
With other substrates similar effects on uncoupling of reduc-
ing equivalents are likely to emerge for II 14V. 
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